Market Research Logo

Genome Editing - Global Market Outlook (2016-2022)

Genome Editing - Global Market Outlook (2016-2022)

According to Stratistics MRC, the Global Genome Editing market is estimated at $2098.9 million in 2015 and is expected to reach $5367.64 million by 2022 growing at a CAGR of 14.3% from 2015 to 2022. Increasing investment and more focus on research and development by companies for new treatment are the key factors driving the market growth. Strict rules imposed by governments across the regions is restraining genome editing market. Technological advancements generate pool of opportunities for market growth.

North America captured huge market share owing to the increase in biotechnology and pharmaceutical industries in United States. However, Asia Pacific is anticipated to be the fastest growing region with highest CAGR during forecast period, because of rapid increase in research and development this region. Pharmaceutical and Biotechnology Companies in end user segment holds largest share in the market.

Some of the key players in the market are Sangamo Biosciences, Inc., Origene Technologies, Inc., MERCK KGAA, Thermo Fisher Scientific, Inc., New England Biolabs, Inc., CELLECTIS S.A., Horizon Discovery Group Plc, Lonza Group Ltd., APPLIED STEMCELL INC., Sigma-Aldrich Corporation, Transposagen Biopharmaceuticals, Inc., Integrated DNA Technologies, Inc and Genscript USA Inc.

Products And Services Covered:
Genome Editing Services
Software
Reagents, Enzymes and Consumables
Delivery Tools
Genome Editing Tools And Kits
Other Reagents, Enzymes And Consumables
Instruments
Cell Lines and Animal Models

Technologies Covered:
Clustered Regularly Interspaced Short Palindromic Repeats (Crispr/Cas9)
Crispr Dcas9
Wt Crispr/Cas9
Crispr/Cas9 Nickase
Transcription Activator-Like Effector Nucleases (Talen)
Zinc Finger Nuclease (Zfn)
Antisense Technology
Other Technologies
Arcus (Homing Endonuclease) And Megatal
Recombinant Adeno-Associated Virus (R Aav)
Targatt And Rapid Trait Development System (Rtds)
Piggybac Transposase And Sleeping Beauty Transposon

Applications Covered:
Plant Biotechnology/Agriculture
Drug Discovery and Development
Clinical
Pre-Clinical
Basic Research
Genomic Visualization
Genomic Screening
Transcription Activation/Repression
Animal Biotechnology
Livestock
Animal Health
Other Animal Biotechnology
Cell Line Engineering

End Users Covered:
Pharmaceutical And Biotechnology Companies
Academic And Government Research Institutes
Plant Biotechnology Companies
Others End Users
Contract Research Organizations (Cro)
Animal Biotechnology

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
Market share assessments for the regional and country level segments
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Genome Editing Market, By Products And Services
5.1 Introduction
5.2 Genome Editing Services
5.3 Software
5.4 Reagents, Enzymes And Consumables
5.4.1 Delivery Tools
5.4.2 Genome Editing Tools And Kits
5.4.3 Other Reagents, Enzymes And Consumables
5.5 Instruments
5.6 Cell Lines And Animal Models
6 Global Genome Editing Market, By Technology
6.1 Introduction
6.2 Clustered Regularly Interspaced Short Palindromic Repeats (Crispr/Cas9)
6.2.1 Crispr Dcas9
6.2.2 Wt Crispr/Cas9
6.2.3 Crispr/Cas9 Nickase
6.3 Transcription Activator-Like Effector Nucleases (Talen)
6.4 Zinc Finger Nuclease (Zfn)
6.5 Antisense Technology
6.6 Other Technologies
6.6.1 Arcus (Homing Endonuclease) And Megatal
6.6.2 Recombinant Adeno-Associated Virus (R Aav)
6.6.3 Targatt And Rapid Trait Development System (Rtds)
6.6.4 Piggybac Transposase And Sleeping Beauty Transposon
7 Global Genome Editing Market, By Application
7.1 Introduction
7.2 Plant Biotechnology/Agriculture
7.3 Drug Discovery And Development
7.3.1 Clinical
7.3.2 Pre-Clinical
7.4 Basic Research
7.4.1 Genomic Visualization
7.4.2 Genomic Screening
7.4.3 Transcription Activation/Repression
7.5 Animal Biotechnology
7.5.1 Livestock
7.5.2 Animal Health
7.5.3 Other Animal Biotechnology
7.6 Cell Line Engineering
8 Global Genome Editing Market, By End User
8.1 Introduction
8.2 Pharmaceutical And Biotechnology Companies
8.3 Academic And Government Research Institutes
8.4 Plant Biotechnology Companies
8.5 Others End Users
8.5.1 Contract Research Organizations (Cro)
8.5.2 Animal Biotechnology
9 Global Genome Editing Market, By Geography
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Sangamo Biosciences, Inc.
11.2 Origene Technologies, Inc. (U.S.)
11.3 MERCK KGAA
11.4 Thermo Fisher Scientific, Inc.
11.5 New England Biolabs, Inc. (U.S.)
11.6 CELLECTIS S.A.
11.7 Horizon Discovery Group Plc
11.8 Lonza Group Ltd. (Switzerland)
11.9 APPLIED STEMCELL INC.
11.10 Sigma-Aldrich Corporation
11.11 Transposagen Biopharmaceuticals, Inc. (U.S.).
11.12 Integrated Dna Technologies, Inc.
11.13 Genscript USA Inc.
List of Tables
Table 1 Global Genome Editing Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Genome Editing Market Outlook, By Products And Services (2013-2022) ($MN)
Table 3 Global Genome Editing Market Outlook, By Genome Editing Services (2013-2022) ($MN)
Table 4 Global Genome Editing Market Outlook, By Software (2013-2022) ($MN)
Table 5 Global Genome Editing Market Outlook, By Reagents, Enzymes And Consumables (2013-2022) ($MN)
Table 6 Global Genome Editing Market Outlook, By Delivery Tools (2013-2022) ($MN)
Table 7 Global Genome Editing Market Outlook, By Genome Editing Tools And Kits (2013-2022) ($MN)
Table 8 Global Genome Editing Market Outlook, By Other Reagents, Enzymes And Consumables (2013-2022) ($MN)
Table 9 Global Genome Editing Market Outlook, By Instruments (2013-2022) ($MN)
Table 10 Global Genome Editing Market Outlook, By Cell Lines And Animal Models (2013-2022) ($MN)
Table 11 Global Genome Editing Market Outlook, By Technology (2013-2022) ($MN)
Table 12 Global Genome Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (Crispr/Cas9) (2013-2022) ($MN)
Table 13 Global Genome Editing Market Outlook, By Crispr Dcas9 (2013-2022) ($MN)
Table 14 Global Genome Editing Market Outlook, By Wt Crispr/Cas9 (2013-2022) ($MN)
Table 15 Global Genome Editing Market Outlook, By Crispr/Cas9 Nickase (2013-2022) ($MN)
Table 16 Global Genome Editing Market Outlook, By Transcription Activator-Like Effector Nucleases (Talen) (2013-2022) ($MN)
Table 17 Global Genome Editing Market Outlook, By Zinc Finger Nuclease (Zfn) (2013-2022) ($MN)
Table 18 Global Genome Editing Market Outlook, By Antisense Technology(2013-2022) ($MN)
Table 19 Global Genome Editing Market Outlook, By Other Technologies (2013-2022) ($MN)
Table 20 Global Genome Editing Market Outlook, By Arcus (Homing Endonuclease) And Megatal (2013-2022) ($MN)
Table 21 Global Genome Editing Market Outlook, By Recombinant Adeno-Associated Virus (R Aav) (2013-2022) ($MN)
Table 22 Global Genome Editing Market Outlook, By Targatt And Rapid Trait Development System (Rtds) (2013-2022) ($MN)
Table 23 Global Genome Editing Market Outlook, By Piggybac Transposase And Sleeping Beauty Transposon (2013-2022) ($MN)
Table 24 Global Genome Editing Market Outlook, By Application (2013-2022) ($MN)
Table 25 Global Genome Editing Market Outlook, By Plant Biotechnology/Agriculture (2013-2022) ($MN)
Table 26 Global Genome Editing Market Outlook, By Drug Discovery And Development (2013-2022) ($MN)
Table 27 Global Genome Editing Market Outlook, By Clinical (2013-2022) ($MN)
Table 28 Global Genome Editing Market Outlook, By Pre-Clinical (2013-2022) ($MN)
Table 29 Global Genome Editing Market Outlook, By Basic Research (2013-2022) ($MN)
Table 30 Global Genome Editing Market Outlook, By Genomic Visualization (2013-2022) ($MN)
Table 31 Global Genome Editing Market Outlook, By Genomic Screening (2013-2022) ($MN)
Table 32 Global Genome Editing Market Outlook, By Transcription Activation/Repression (2013-2022) ($MN)
Table 33 Global Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
Table 34 Global Genome Editing Market Outlook, By Livestock (2013-2022) ($MN)
Table 35 Global Genome Editing Market Outlook, By Animal Health (2013-2022) ($MN)
Table 36 Global Genome Editing Market Outlook, By Other Animal Biotechnology (2013-2022) ($MN)
Table 37 Global Genome Editing Market Outlook, By Cell Line Engineering (2013-2022) ($MN)
Table 38 Global Genome Editing Market Outlook, By End User (2013-2022) ($MN)
Table 39 Global Genome Editing Market Outlook, By Pharmaceutical And Biotechnology Companies (2013-2022) ($MN)
Table 40 Global Genome Editing Market Outlook, By Academic And Government Research Institutes (2013-2022) ($MN)
Table 41 Global Genome Editing Market Outlook, By Plant Biotechnology Companies (2013-2022) ($MN)
Table 42 Global Genome Editing Market Outlook, By Others End Users (2013-2022) ($MN)
Table 43 Global Genome Editing Market Outlook, By Contract Research Organizations (Cro) (2013-2022) ($MN)
Table 44 Global Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
Table 45 North America Genome Editing Market Outlook, By Country (2013-2022) ($MN)
Table 46 North America Genome Editing Market Outlook, By Products And Services (2013-2022) ($MN)
Table 47 North America Genome Editing Market Outlook, By Genome Editing Services (2013-2022) ($MN)
Table 48 North America Genome Editing Market Outlook, By Software (2013-2022) ($MN)
Table 49 North America Genome Editing Market Outlook, By Reagents, Enzymes And Consumables (2013-2022) ($MN)
Table 50 North America Genome Editing Market Outlook, By Delivery Tools (2013-2022) ($MN)
Table 51 North America Genome Editing Market Outlook, By Genome Editing Tools And Kits (2013-2022) ($MN)
Table 52 North America Genome Editing Market Outlook, By Other Reagents, Enzymes And Consumables (2013-2022) ($MN)
Table 53 North America Genome Editing Market Outlook, By Instruments (2013-2022) ($MN)
Table 54 North America Genome Editing Market Outlook, By Cell Lines And Animal Models (2013-2022) ($MN)
Table 55 North America Genome Editing Market Outlook, By Technology (2013-2022) ($MN)
Table 56 North America Genome Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (Crispr/Cas9) (2013-2022) ($MN)
Table 57 North America Genome Editing Market Outlook, By Crispr Dcas9 (2013-2022) ($MN)
Table 58 North America Genome Editing Market Outlook, By Wt Crispr/Cas9 (2013-2022) ($MN)
Table 59 North America Genome Editing Market Outlook, By Crispr/Cas9 Nickase (2013-2022) ($MN)
Table 60 North America Genome Editing Market Outlook, By Transcription Activator-Like Effector Nucleases (Talen) (2013-2022) ($MN)
Table 61 North America Genome Editing Market Outlook, By Zinc Finger Nuclease (Zfn) (2013-2022) ($MN)
Table 62 North America Genome Editing Market Outlook, By Antisense Technology(2013-2022) ($MN)
Table 63 North America Genome Editing Market Outlook, By Other Technologies (2013-2022) ($MN)
Table 64 North America Genome Editing Market Outlook, By Arcus (Homing Endonuclease) And Megatal (2013-2022) ($MN)
Table 65 North America Genome Editing Market Outlook, By Recombinant Adeno-Associated Virus (R Aav) (2013-2022) ($MN)
Table 66 North America Genome Editing Market Outlook, By Targatt And Rapid Trait Development System (Rtds) (2013-2022) ($MN)
Table 67 North America Genome Editing Market Outlook, By Piggybac Transposase And Sleeping Beauty Transposon (2013-2022) ($MN)
Table 68 North America Genome Editing Market Outlook, By Application (2013-2022) ($MN)
Table 69 North America Genome Editing Market Outlook, By Plant Biotechnology/Agriculture (2013-2022) ($MN)
Table 70 North America Genome Editing Market Outlook, By Drug Discovery And Development (2013-2022) ($MN)
Table 71 North America Genome Editing Market Outlook, By Clinical (2013-2022) ($MN)
Table 72 North America Genome Editing Market Outlook, By Pre-Clinical (2013-2022) ($MN)
Table 73 North America Genome Editing Market Outlook, By Basic Research (2013-2022) ($MN)
Table 74 North America Genome Editing Market Outlook, By Genomic Visualization (2013-2022) ($MN)
Table 75 North America Genome Editing Market Outlook, By Genomic Screening (2013-2022) ($MN)
Table 76 North America Genome Editing Market Outlook, By Transcription Activation/Repression (2013-2022) ($MN)
Table 77 North America Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
Table 78 North America Genome Editing Market Outlook, By Livestock (2013-2022) ($MN)
Table 79 North America Genome Editing Market Outlook, By Animal Health (2013-2022) ($MN)
Table 80 North America Genome Editing Market Outlook, By Other Animal Biotechnology (2013-2022) ($MN)
Table 81 North America Genome Editing Market Outlook, By Cell Line Engineering (2013-2022) ($MN)
Table 82 North America Genome Editing Market Outlook, By End User (2013-2022) ($MN)
Table 83 North America Genome Editing Market Outlook, By Pharmaceutical And Biotechnology Companies (2013-2022) ($MN)
Table 84 North America Genome Editing Market Outlook, By Academic And Government Research Institutes (2013-2022) ($MN)
Table 85 North America Genome Editing Market Outlook, By Plant Biotechnology Companies (2013-2022) ($MN)
Table 86 North America Genome Editing Market Outlook, By Others End Users (2013-2022) ($MN)
Table 87 North America Genome Editing Market Outlook, By Contract Research Organizations (Cro) (2013-2022) ($MN)
Table 88 North America Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
Table 89 Europe Genome Editing Market Outlook, By Country (2013-2022) ($MN)
Table 90 Europe Genome Editing Market Outlook, By Products And Services (2013-2022) ($MN)
Table 91 Europe Genome Editing Market Outlook, By Genome Editing Services (2013-2022) ($MN)
Table 92 Europe Genome Editing Market Outlook, By Software (2013-2022) ($MN)
Table 93 Europe Genome Editing Market Outlook, By Reagents, Enzymes And Consumables (2013-2022) ($MN)
Table 94 Europe Genome Editing Market Outlook, By Delivery Tools (2013-2022) ($MN)
Table 95 Europe Genome Editing Market Outlook, By Genome Editing Tools And Kits (2013-2022) ($MN)
Table 96 Europe Genome Editing Market Outlook, By Other Reagents, Enzymes And Consumables (2013-2022) ($MN)
Table 97 Europe Genome Editing Market Outlook, By Instruments (2013-2022) ($MN)
Table 98 Europe Genome Editing Market Outlook, By Cell Lines And Animal Models (2013-2022) ($MN)
Table 99 Europe Genome Editing Market Outlook, By Technology (2013-2022) ($MN)
Table 100 Europe Genome Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (Crispr/Cas9) (2013-2022) ($MN)
Table 101 Europe Genome Editing Market Outlook, By Crispr Dcas9 (2013-2022) ($MN)
Table 102 Europe Genome Editing Market Outlook, By Wt Crispr/Cas9 (2013-2022) ($MN)
Table 103 Europe Genome Editing Market Outlook, By Crispr/Cas9 Nickase (2013-2022) ($MN)
Table 104 Europe Genome Editing Market Outlook, By Transcription Activator-Like Effector Nucleases (Talen) (2013-2022) ($MN)
Table 105 Europe Genome Editing Market Outlook, By Zinc Finger Nuclease (Zfn) (2013-2022) ($MN)
Table 106 Europe Genome Editing Market Outlook, By Antisense Technology(2013-2022) ($MN)
Table 107 Europe Genome Editing Market Outlook, By Other Technologies (2013-2022) ($MN)
Table 108 Europe Genome Editing Market Outlook, By Arcus (Homing Endonuclease) And Megatal (2013-2022) ($MN)
Table 109 Europe Genome Editing Market Outlook, By Recombinant Adeno-Associated Virus (R Aav) (2013-2022) ($MN)
Table 110 Europe Genome Editing Market Outlook, By Targatt And Rapid Trait Development System (Rtds) (2013-2022) ($MN)
Table 111 Europe Genome Editing Market Outlook, By Piggybac Transposase And Sleeping Beauty Transposon (2013-2022) ($MN)
Table 112 Europe Genome Editing Market Outlook, By Application (2013-2022) ($MN)
Table 113 Europe Genome Editing Market Outlook, By Plant Biotechnology/Agriculture (2013-2022) ($MN)
Table 114 Europe Genome Editing Market Outlook, By Drug Discovery And Development (2013-2022) ($MN)
Table 115 Europe Genome Editing Market Outlook, By Clinical (2013-2022) ($MN)
Table 116 Europe Genome Editing Market Outlook, By Pre-Clinical (2013-2022) ($MN)
Table 117 Europe Genome Editing Market Outlook, By Basic Research (2013-2022) ($MN)
Table 118 Europe Genome Editing Market Outlook, By Genomic Visualization (2013-2022) ($MN)
Table 119 Europe Genome Editing Market Outlook, By Genomic Screening (2013-2022) ($MN)
Table 120 Europe Genome Editing Market Outlook, By Transcription Activation/Repression (2013-2022) ($MN)
Table 121 Europe Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
Table 122 Europe Genome Editing Market Outlook, By Livestock (2013-2022) ($MN)
Table 123 Europe Genome Editing Market Outlook, By Animal Health (2013-2022) ($MN)
Table 124 Europe Genome Editing Market Outlook, By Other Animal Biotechnology (2013-2022) ($MN)
Table 125 Europe Genome Editing Market Outlook, By Cell Line Engineering (2013-2022) ($MN)
Table 126 Europe Genome Editing Market Outlook, By End User (2013-2022) ($MN)
Table 127 Europe Genome Editing Market Outlook, By Pharmaceutical And Biotechnology Companies (2013-2022) ($MN)
Table 128 Europe Genome Editing Market Outlook, By Academic And Government Research Institutes (2013-2022) ($MN)
Table 129 Europe Genome Editing Market Outlook, By Plant Biotechnology Companies (2013-2022) ($MN)
Table 130 Europe Genome Editing Market Outlook, By Others End Users (2013-2022) ($MN)
Table 131 Europe Genome Editing Market Outlook, By Contract Research Organizations (Cro) (2013-2022) ($MN)
Table 132 Europe Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
Table 133 Asia Pacific Genome Editing Market Outlook, By Country (2013-2022) ($MN)
Table 134 Asia Pacific Genome Editing Market Outlook, By Products And Services (2013-2022) ($MN)
Table 135 Asia Pacific Genome Editing Market Outlook, By Genome Editing Services (2013-2022) ($MN)
Table 136 Asia Pacific Genome Editing Market Outlook, By Software (2013-2022) ($MN)
Table 137 Asia Pacific Genome Editing Market Outlook, By Reagents, Enzymes And Consumables (2013-2022) ($MN)
Table 138 Asia Pacific Genome Editing Market Outlook, By Delivery Tools (2013-2022) ($MN)
Table 139 Asia Pacific Genome Editing Market Outlook, By Genome Editing Tools And Kits (2013-2022) ($MN)
Table 140 Asia Pacific Genome Editing Market Outlook, By Other Reagents, Enzymes And Consumables (2013-2022) ($MN)
Table 141 Asia Pacific Genome Editing Market Outlook, By Instruments (2013-2022) ($MN)
Table 142 Asia Pacific Genome Editing Market Outlook, By Cell Lines And Animal Models (2013-2022) ($MN)
Table 143 Asia Pacific Genome Editing Market Outlook, By Technology (2013-2022) ($MN)
Table 144 Asia Pacific Genome Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (Crispr/Cas9) (2013-2022) ($MN)
Table 145 Asia Pacific Genome Editing Market Outlook, By Crispr Dcas9 (2013-2022) ($MN)
Table 146 Asia Pacific Genome Editing Market Outlook, By Wt Crispr/Cas9 (2013-2022) ($MN)
Table 147 Asia Pacific Genome Editing Market Outlook, By Crispr/Cas9 Nickase (2013-2022) ($MN)
Table 148 Asia Pacific Genome Editing Market Outlook, By Transcription Activator-Like Effector Nucleases (Talen) (2013-2022) ($MN)
Table 149 Asia Pacific Genome Editing Market Outlook, By Zinc Finger Nuclease (Zfn) (2013-2022) ($MN)
Table 150 Asia Pacific Genome Editing Market Outlook, By Antisense Technology(2013-2022) ($MN)
Table 151 Asia Pacific Genome Editing Market Outlook, By Other Technologies (2013-2022) ($MN)
Table 152 Asia Pacific Genome Editing Market Outlook, By Arcus (Homing Endonuclease) And Megatal (2013-2022) ($MN)
Table 153 Asia Pacific Genome Editing Market Outlook, By Recombinant Adeno-Associated Virus (R Aav) (2013-2022) ($MN)
Table 154 Asia Pacific Genome Editing Market Outlook, By Targatt And Rapid Trait Development System (Rtds) (2013-2022) ($MN)
Table 155 Asia Pacific Genome Editing Market Outlook, By Piggybac Transposase And Sleeping Beauty Transposon (2013-2022) ($MN)
Table 156 Asia Pacific Genome Editing Market Outlook, By Application (2013-2022) ($MN)
Table 157 Asia Pacific Genome Editing Market Outlook, By Plant Biotechnology/Agriculture (2013-2022) ($MN)
Table 158 Asia Pacific Genome Editing Market Outlook, By Drug Discovery And Development (2013-2022) ($MN)
Table 159 Asia Pacific Genome Editing Market Outlook, By Clinical (2013-2022) ($MN)
Table 160 Asia Pacific Genome Editing Market Outlook, By Pre-Clinical (2013-2022) ($MN)
Table 161 Asia Pacific Genome Editing Market Outlook, By Basic Research (2013-2022) ($MN)
Table 162 Asia Pacific Genome Editing Market Outlook, By Genomic Visualization (2013-2022) ($MN)
Table 163 Asia Pacific Genome Editing Market Outlook, By Genomic Screening (2013-2022) ($MN)
Table 164 Asia Pacific Genome Editing Market Outlook, By Transcription Activation/Repression (2013-2022) ($MN)
Table 165 Asia Pacific Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
Table 166 Asia Pacific Genome Editing Market Outlook, By Livestock (2013-2022) ($MN)
Table 167 Asia Pacific Genome Editing Market Outlook, By Animal Health (2013-2022) ($MN)
Table 168 Asia Pacific Genome Editing Market Outlook, By Other Animal Biotechnology (2013-2022) ($MN)
Table 169 Asia Pacific Genome Editing Market Outlook, By Cell Line Engineering (2013-2022) ($MN)
Table 170 Asia Pacific Genome Editing Market Outlook, By End User (2013-2022) ($MN)
Table 171 Asia Pacific Genome Editing Market Outlook, By Pharmaceutical And Biotechnology Companies (2013-2022) ($MN)
Table 172 Asia Pacific Genome Editing Market Outlook, By Academic And Government Research Institutes (2013-2022) ($MN)
Table 173 Asia Pacific Genome Editing Market Outlook, By Plant Biotechnology Companies (2013-2022) ($MN)
Table 174 Asia Pacific Genome Editing Market Outlook, By Others End Users (2013-2022) ($MN)
Table 175 Asia Pacific Genome Editing Market Outlook, By Contract Research Organizations (Cro) (2013-2022) ($MN)
Table 176 Asia Pacific Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
Table 177 RoW Genome Editing Market Outlook, By Country (2013-2022) ($MN)
Table 178 RoW Genome Editing Market Outlook, By Products And Services (2013-2022) ($MN)
Table 179 RoW Genome Editing Market Outlook, By Genome Editing Services (2013-2022) ($MN)
Table 180 RoW Genome Editing Market Outlook, By Software (2013-2022) ($MN)
Table 181 RoW Genome Editing Market Outlook, By Reagents, Enzymes And Consumables (2013-2022) ($MN)
Table 182 RoW Genome Editing Market Outlook, By Delivery Tools (2013-2022) ($MN)
Table 183 RoW Genome Editing Market Outlook, By Genome Editing Tools and Kits (2013-2022) ($MN)
Table 184 RoW Genome Editing Market Outlook, By Other Reagents, Enzymes and Consumables (2013-2022) ($MN)
Table 185 RoW Genome Editing Market Outlook, By Instruments (2013-2022) ($MN)
Table 186 RoW Genome Editing Market Outlook, By Cell Lines and Animal Models (2013-2022) ($MN)
Table 187 RoW Genome Editing Market Outlook, By Technology (2013-2022) ($MN)
Table 188 RoW Genome Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (Crispr/Cas9) (2013-2022) ($MN)
Table 189 RoW Genome Editing Market Outlook, By Crispr Dcas9 (2013-2022) ($MN)
Table 190 RoW Genome Editing Market Outlook, By Wt Crispr/Cas9 (2013-2022) ($MN)
Table 191 RoW Genome Editing Market Outlook, By Crispr/Cas9 Nickase (2013-2022) ($MN)
Table 192 RoW Genome Editing Market Outlook, By Transcription Activator-Like Effector Nucleases (Talen) (2013-2022) ($MN)
Table 193 RoW Genome Editing Market Outlook, By Zinc Finger Nuclease (Zfn) (2013-2022) ($MN)
Table 194 RoW Genome Editing Market Outlook, By Antisense Technology(2013-2022) ($MN)
Table 195 RoW Genome Editing Market Outlook, By Other Technologies (2013-2022) ($MN)
Table 196 RoW Genome Editing Market Outlook, By Arcus (Homing Endonuclease) And Megatal (2013-2022) ($MN)
Table 197 RoW Genome Editing Market Outlook, By Recombinant Adeno-Associated Virus (R Aav) (2013-2022) ($MN)
Table 198 RoW Genome Editing Market Outlook, By Targatt and Rapid Trait Development System (Rtds) (2013-2022) ($MN)
Table 199 RoW Genome Editing Market Outlook, By Piggybac Transposase And Sleeping Beauty Transposon (2013-2022) ($MN)
Table 200 RoW Genome Editing Market Outlook, By Application (2013-2022) ($MN)
Table 201 RoW Genome Editing Market Outlook, By Plant Biotechnology/Agriculture (2013-2022) ($MN)
Table 202 RoW Genome Editing Market Outlook, By Drug Discovery and Development (2013-2022) ($MN)
Table 203 RoW Genome Editing Market Outlook, By Clinical (2013-2022) ($MN)
Table 204 RoW Genome Editing Market Outlook, By Pre-Clinical (2013-2022) ($MN)
Table 205 RoW Genome Editing Market Outlook, By Basic Research (2013-2022) ($MN)
Table 206 RoW Genome Editing Market Outlook, By Genomic Visualization (2013-2022) ($MN)
Table 207 RoW Genome Editing Market Outlook, By Genomic Screening (2013-2022) ($MN)
Table 208 RoW Genome Editing Market Outlook, By Transcription Activation/Repression (2013-2022) ($MN)
Table 209 RoW Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
Table 210 RoW Genome Editing Market Outlook, By Livestock (2013-2022) ($MN)
Table 211 RoW Genome Editing Market Outlook, By Animal Health (2013-2022) ($MN)
Table 212 RoW Genome Editing Market Outlook, By Other Animal Biotechnology (2013-2022) ($MN)
Table 213 RoW Genome Editing Market Outlook, By Cell Line Engineering (2013-2022) ($MN)
Table 214 RoW Genome Editing Market Outlook, By End User (2013-2022) ($MN)
Table 215 RoW Genome Editing Market Outlook, By Pharmaceutical and Biotechnology Companies (2013-2022) ($MN)
Table 216 RoW Genome Editing Market Outlook, By Academic and Government Research Institutes (2013-2022) ($MN)
Table 217 RoW Genome Editing Market Outlook, By Plant Biotechnology Companies (2013-2022) ($MN)
Table 218 RoW Genome Editing Market Outlook, By Others End Users (2013-2022) ($MN)
Table 219 RoW Genome Editing Market Outlook, By Contract Research Organizations (Cro) (2013-2022) ($MN)
Table 220 RoW Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report